Secondary CIC-rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report

• Kimbara, Shiro

• Imamura, Yoshinori

• Kiyota, Naomi

• Takakura, Hidetomo

• Matsumoto, Sakuya

• Koyama, Taiji

• Fujishima, Yoshimi

• Funakoshi, Yohei

• Toyoda, Masanori

• Hirose, Takanori

• Kanzawa, Maki

• Kawamoto, Teruya

• Hara, Hitomi

• Minami, Hironobu

Abstract

Capicua transcriptional repressor (CIC)-rearranged sarcoma is an Ewing-like sarcoma with an aggressive clinical course and poor prognosis. No standard treatment has been established. The present study describes a case of CIC-rearranged sarcoma with lung metastases developing in a 24-year-old woman as a therapy-associated malignancy following chemotherapy for anaplastic large cell lymphoma at nine years old. This was treated with palliative regimens used for Ewing sarcoma. The patient achieved disease control for one year. Of note, ifosfamide and etoposide (IE), which were used as a second line treatment lead to a partial response. The case described in the present study indicated that treatment with Ewing regimens is a reasonable option for patients with metastatic CIC-rearranged sarcoma, including those with a second malignant case.

Journal

• Molecular and Clinical Oncology

  Molecular and Clinical Oncology 14 (4), 68-68, 2021-04

  Spandidos Publications

Keywords

• CIC-rearranged sarcoma
• Ewing-like sarcoma
• chemotherapy
• ifosfamide
• etoposide
• secondary sarcoma

Details

• CRID: 1050012570391822464
• NII Article ID: 120006975747
• NII Book ID: AA12610944
• ISSN: 20499469
• ISSN: 20499450
• HANDLE: 20.500.14094/90007940
• Text Lang: en
• Article Type: journal article
• Data Source:
  • IRDB
  • CiNii Articles